GLP-1 drugs: what Alabama Medicaid paid

Q: Does a paid prescription mean Alabama Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Alabama Medicaid shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Alabama Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Alabama Medicaid’s payment record shows

In 2026Q1, the product Alabama Medicaid paid for most often was Ozempic®, at 9,651 prescriptions¹⁹ of the 18,470 to 18,542^{1,7,13,19,25,37,43} across all 8 products, or 52 percent of the published count.

Alabama Medicaid itself reimbursed at least $18,823,631 for these products in the quarter, about $1,020 per prescription. Pharmacies were paid $19,190,904 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,319.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Alabama Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Alabama Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Alabama Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Alabama Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	at least 859¹	5%	$915,600	$920,454	$1,066
tirzepatideMounjaro®	Fee-for-service	at least 7,007⁷	38%	$7,423,960	$7,604,947	$1,060
semaglutideWegovy®	Fee-for-service	212¹³	1%	$279,714	$281,969	$1,319
semaglutideOzempic®	Fee-for-service	at least 9,651¹⁹	52%	$9,524,779	$9,695,521	$987
semaglutideRybelsus®	Fee-for-service	625²⁵	3%	$621,646	$629,745	$995
liraglutideSaxenda®	Not published	No row	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	48³⁷	<1%	$31,420	$31,526	$655
liraglutideliraglutide (generic)	Fee-for-service	at least 60⁴³	<1%	$26,511	$26,743	$442

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 673 against 1,629. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 24.7 to 24.8 prescriptions per thousand people enrolled in Alabama Medicaid, on an average of 747,304 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 1 of the 168 product-quarters it holds a row for here, which is 1 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Across every quarter on file, the federal record holds no row at all for Saxenda®. That is an absence in the file rather than a refusal by Alabama Medicaid: no prescription was reported, and the reason is not published here.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Alabama Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Alabama Medicaid paid for each product, quarter by quarter

Prescriptions Alabama Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter²No row	at least 137 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$143,855 paid	at least 332 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$352,786 paid	574 paid prescriptions in the quarter (2025Q4)²Count$609,527 paid	at least 859 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$915,600 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 61 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$57,705 paid	at least 393 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$364,712 paid	at least 1,064 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$1,030,968 paid	at least 1,658 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$1,609,581 paid	at least 2,175 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$2,100,959 paid	at least 2,804 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$2,722,931 paid	at least 3,372 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$3,393,631 paid	at least 3,104 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$3,168,392 paid	at least 3,721 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$3,816,043 paid	at least 4,360 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$4,467,138 paid	at least 5,056 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$5,203,644 paid	at least 4,929 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$5,087,182 paid	at least 4,315 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$4,477,474 paid	at least 4,461 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$4,648,549 paid	at least 7,007 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$7,423,960 paid
semaglutideWegovy®range 168 to 212, up 44 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	at least 21 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$27,500 paid	at least 43 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$56,850 paid	at least 89 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$117,846 paid	at least 128 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$170,401 paid	168 paid prescriptions in the quarter (2025Q4)¹⁴Count$223,336 paid	212 paid prescriptions in the quarter (2026Q1)¹³Count$279,714 paid
semaglutideOzempic®range 1,137 to 7,888	1,137 paid prescriptions in the quarter (2021Q1)²⁴Count$906,665 paid	1,188 paid prescriptions in the quarter (2021Q2)²⁴Count$977,783 paid	at least 1,056 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$864,539 paid	at least 1,556 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$1,282,799 paid	at least 1,562 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$1,319,970 paid	at least 2,066 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$1,775,612 paid	at least 2,291 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,968,551 paid	at least 2,388 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$2,054,551 paid	at least 3,038 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$2,699,714 paid	at least 3,394 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$3,027,994 paid	at least 3,475 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$3,115,998 paid	at least 3,397 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$3,084,011 paid	at least 4,161 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$3,848,046 paid	at least 5,928 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$5,501,675 paid	at least 6,438 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$6,022,219 paid	at least 7,233 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$6,755,825 paid	at least 7,929 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$7,552,928 paid	at least 8,177 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$7,853,019 paid	7,888 paid prescriptions in the quarter (2025Q3)²⁰Count$7,596,363 paid	at least 8,973 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$8,656,575 paid	at least 9,651 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$9,524,779 paid
semaglutideRybelsus®range 104 to 687, up 36 on the quarter before	104 paid prescriptions in the quarter (2021Q1)³⁰Count$82,506 paid	158 paid prescriptions in the quarter (2021Q2)³⁰Count$127,146 paid	186 paid prescriptions in the quarter (2021Q3)³⁰Count$154,684 paid	at least 270 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$229,142 paid	at least 250 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$218,394 paid	at least 283 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$246,736 paid	at least 332 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$288,809 paid	at least 312 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$266,264 paid	at least 421 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$371,091 paid	472 paid prescriptions in the quarter (2023Q2)²⁸Count$422,844 paid	452 paid prescriptions in the quarter (2023Q3)²⁸Count$410,574 paid	469 paid prescriptions in the quarter (2023Q4)²⁸Count$426,319 paid	531 paid prescriptions in the quarter (2024Q1)²⁷Count$494,979 paid	655 paid prescriptions in the quarter (2024Q2)²⁷Count$611,780 paid	630 paid prescriptions in the quarter (2024Q3)²⁷Count$590,848 paid	677 paid prescriptions in the quarter (2024Q4)²⁷Count$634,407 paid	687 paid prescriptions in the quarter (2025Q1)²⁶Count$659,903 paid	608 paid prescriptions in the quarter (2025Q2)²⁶Count$587,028 paid	523 paid prescriptions in the quarter (2025Q3)²⁶Count$503,423 paid	589 paid prescriptions in the quarter (2025Q4)²⁶Count$564,715 paid	625 paid prescriptions in the quarter (2026Q1)²⁵Count$621,646 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 42 to 1,731, down 4 on the quarter before	1,525 paid prescriptions in the quarter (2021Q1)⁴²Count$1,246,820 paid	1,363 paid prescriptions in the quarter (2021Q2)⁴²Count$1,162,009 paid	1,227 paid prescriptions in the quarter (2021Q3)⁴²Count$1,056,170 paid	1,408 paid prescriptions in the quarter (2021Q4)⁴²Count$1,204,110 paid	1,071 paid prescriptions in the quarter (2022Q1)⁴¹Count$942,637 paid	1,176 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,033,753 paid	1,144 paid prescriptions in the quarter (2022Q3)⁴¹Count$1,020,158 paid	1,069 paid prescriptions in the quarter (2022Q4)⁴¹Count$942,473 paid	1,731 paid prescriptions in the quarter (2023Q1)⁴⁰Count$1,525,531 paid	1,704 paid prescriptions in the quarter (2023Q2)⁴⁰Count$1,520,873 paid	1,286 paid prescriptions in the quarter (2023Q3)⁴⁰Count$1,174,890 paid	1,078 paid prescriptions in the quarter (2023Q4)⁴⁰Count$978,118 paid	1,016 paid prescriptions in the quarter (2024Q1)³⁹Count$742,653 paid	596 paid prescriptions in the quarter (2024Q2)³⁹Count$394,403 paid	200 paid prescriptions in the quarter (2024Q3)³⁹Count$131,566 paid	139 paid prescriptions in the quarter (2024Q4)³⁹Count$94,596 paid	at least 14 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$9,954 paid	48 paid prescriptions in the quarter (2025Q2)³⁸Count$28,021 paid	42 paid prescriptions in the quarter (2025Q3)³⁸Count$23,269 paid	52 paid prescriptions in the quarter (2025Q4)³⁸Count$29,553 paid	48 paid prescriptions in the quarter (2026Q1)³⁷Count$31,420 paid
liraglutideliraglutide (generic)range 254 to 399	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	254 paid prescriptions in the quarter (2024Q3)⁴⁵Count$152,504 paid	343 paid prescriptions in the quarter (2024Q4)⁴⁵Count$189,542 paid	399 paid prescriptions in the quarter (2025Q1)⁴⁴Count$210,203 paid	at least 174 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$91,372 paid	at least 71 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$34,584 paid	at least 76 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$36,582 paid	at least 60 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$26,511 paid

What this page cannot tell you

Whether Alabama Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Alabama in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, AL
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "272"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, AL
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "183"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, AL
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like ZEPBOUND%, state AL, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, AL
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like ZEPBOUND%, state AL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, AL
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like ZEPBOUND%, state AL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, AL
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like ZEPBOUND%, state AL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, AL
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "1473"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, AL
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1375"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, AL
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1322"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, AL
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "942"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, AL
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "220"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, AL
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like MOUNJARO%, state AL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, AL
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "54"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, AL
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "WEGOVY 0.5", "suppression_used": "false", "number_of_prescriptions": "53"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, AL
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "21"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, AL
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like WEGOVY%, state AL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, AL
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like WEGOVY%, state AL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, AL
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like WEGOVY%, state AL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, AL
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "3407"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, AL
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "3371"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, AL
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "3043"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, AL
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1535"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, AL
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1208"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, AL
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "951"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, AL
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "285"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, AL
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "303"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, AL
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "315"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, AL
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "227"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, AL
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "181"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, AL
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "129"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, AL
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like SAXENDA%, state AL, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, AL
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like SAXENDA%, state AL, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, AL
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like SAXENDA%, state AL, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, AL
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like SAXENDA%, state AL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, AL
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like SAXENDA%, state AL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, AL
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like SAXENDA%, state AL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, AL
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "30"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, AL
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "34"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, AL
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "619"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, AL
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "928"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, AL
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2022", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "723"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, AL
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "886"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, AL
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state AL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AL", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "22"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, AL
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state AL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "170"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, AL
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state AL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "201"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, AL
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state AL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like LIRAGLUTID%, state AL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, AL
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state AL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like LIRAGLUTID%, state AL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, AL
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state AL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AL", "product_name": "product_name like LIRAGLUTID%, state AL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 31 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 17 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Alabama Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.